Chart showing quality-of-life concerns reported by 55 people with chronic pulmonary aspergillosis (CPA) in a 2021 patient survey, including fatigue, breathlessness and loss of fitness.

What Worries People with CPA Most? Patients Tell Us

 

Living with CPA: What matters most to patients?

Chronic pulmonary aspergillosis (CPA) is often described in terms of lung damage, fungal infection, scans and antifungal treatment. But these medical descriptions do not always capture what matters most to people living with the condition.

In October 2021, we asked members of our aspergillosis patient support community a simple question:

What aspect(s) of your current quality of life are you most concerned about and would like to improve the most?

The poll was aimed specifically at people living with CPA, and 55 patients responded.

What did patients tell us?

Three concerns stood out particularly strongly:

  • Fatigue: Persistent exhaustion and reduced energy.
  • Breathlessness: Difficulty breathing during everyday activities.
  • Loss of fitness: Reduced stamina, strength and ability to remain active.

These were the leading concerns in the poll, but patients also identified a much wider range of difficulties.

Other concerns included anxiety, coughing, side effects from antifungal medication, weight loss and changes in emotional wellbeing.

Some respondents identified only one concern, while others selected as many as 15. This illustrates how differently CPA can affect people's everyday lives.

The original patient survey

Survey date: 6 October 2021
Participants: 55 people with CPA
Setting: Aspergillosis patient support community Facebook poll

Original survey chart: Patient-reported quality-of-life concerns among 55 respondents with CPA, October 2021.

Why fatigue matters so much

Fatigue was one of the most prominent concerns. For people with CPA, tiredness can be more than simply needing extra sleep. It may affect concentration, independence, social activities and the ability to manage ordinary daily tasks.

Fatigue may have several contributing causes, including chronic illness, disturbed sleep, other lung conditions, medication effects and reduced physical conditioning.

Read more in our guides to managing fatigue and energy with aspergillosis.

Breathlessness and loss of fitness

Breathlessness and reduced fitness were also major concerns.

These problems can reinforce one another. Breathlessness may discourage activity, while reduced activity can lead to loss of muscle strength and stamina, making everyday tasks more demanding.

Appropriate exercise, pacing, physiotherapy and pulmonary rehabilitation may help some patients improve their confidence and physical functioning, even when underlying lung damage cannot be reversed.

Read more:

More than a lung infection

One of the most important findings was the diversity of concerns patients identified.

Alongside recognised CPA symptoms, people raised issues involving emotional wellbeing, medication side effects, changes in weight and practical restrictions on everyday life.

These experiences remind us that managing CPA involves more than controlling fungal infection. Treatment decisions and follow-up should also consider how patients are feeling and functioning.

A scan or blood test may provide valuable information about disease activity, but it cannot fully describe someone's quality of life.

What can we learn from this survey?

The survey helped identify subjects that patients wanted more information and support about, particularly fatigue, breathlessness and maintaining physical activity.

These concerns remain important topics for patient education, support meetings and conversations with healthcare professionals.

The findings also illustrate why asking patients directly about their priorities can reveal needs that may receive less attention during routine clinical assessments.

Understanding the limitations

This was an informal, self-selected poll among members of an online patient support community, not a representative clinical study.

Respondents could select multiple concerns. The results therefore describe the priorities of these 55 participants, rather than establishing how common particular symptoms are among all people with CPA.

The poll was conducted in 2021, so it should also be understood as a historical snapshot of patient experience.

Nevertheless, it provides valuable insight into the concerns that motivated members of our community to seek information and support.

What matters most to you?

People living with CPA may have very different priorities. Some are most concerned about breathlessness or fatigue. Others worry about treatment side effects, uncertainty about the future, or maintaining independence.

If you live with CPA, consider discussing the symptoms and difficulties that most affect your quality of life with your healthcare team. These concerns are an important part of planning your care.

Source: Aspergillosis patient support community poll, 6 October 2021, 55 respondents. Historical patient experience information.


Person organising prescribed medicines using a weekly pill organiser, medication list and smartphone reminders.

Managing Your Aspergillosis Medicines: Practical Tips for Staying Safe

Person organising prescribed medicines using a weekly pill organiser, medication list and smartphone reminders.
Keeping an up-to-date medication list and using reminders can help people with aspergillosis manage complex treatments safely.

Living with aspergillosis can mean taking several medicines every day, sometimes for months or years. These may include antifungal medicines, inhalers, corticosteroids, antibiotics and treatments for other health conditions.

Keeping track of everything can become difficult, particularly when you are tired, unwell or experiencing side effects. Fortunately, a few simple routines can make treatment easier to manage and reduce the risk of mistakes.

This guide explains how to organise your medicines, avoid common problems and work effectively with your healthcare team.

Why medication management matters

Some medicines used to treat aspergillosis require particularly careful handling. Antifungal medicines can interact with other prescribed treatments, and certain medicines need regular blood tests or specific instructions about when and how to take them.

People with ABPA may also take corticosteroids, while those with CPA may require long courses of antifungal treatment. Some patients have other conditions, such as asthma, bronchiectasis or diabetes, which add further medicines to their daily routine.

Good medication management helps you:

  • Take the correct medicine at the correct dose and time.
  • Avoid accidentally missing or doubling doses.
  • Recognise possible side effects.
  • Keep track of blood tests and follow-up appointments.
  • Make sure different healthcare professionals know what you are taking.
  • Feel more confident about managing treatment at home.

1. Keep an up-to-date medication list

One of the most useful things you can do is keep a current list of all your medicines.

Include:

  • The name of each medicine.
  • The strength and prescribed dose.
  • When and how you take it.
  • Why you are taking it.
  • Any allergies or previous serious reactions.
  • Over-the-counter medicines, herbal products and supplements.

Keep a copy on your phone or in your wallet. A printed copy can be particularly helpful during an unexpected hospital admission or when attending a new clinic.

Update your list whenever a medicine is started, stopped or changed.

Practical tip: Ask your pharmacist or GP practice for a current repeat prescription list, then check that it matches what you actually take. Hospital-prescribed medicines may not always appear immediately on your GP record.

2. Make taking medicines part of your daily routine

Taking medicines consistently can be challenging when different treatments have different schedules.

Some people find it helpful to use:

  • Phone alarms or medication reminder apps.
  • A written daily medication chart.
  • A calendar for weekly or less frequent medicines.
  • A medicine diary to record doses and any problems.
  • A pharmacy-prepared medication organiser, where suitable.

Linking medicines to regular daily activities can help, but always follow the instructions for the individual medicine. Some antifungal formulations have specific requirements concerning food, stomach acidity or other medicines.

Important: Do not transfer medicines into a pill organiser without checking with your pharmacist. Some need to remain in their original packaging because of stability, moisture protection or other handling requirements.

3. Check instructions carefully when starting an antifungal

Antifungal medicines are not all taken in the same way.

For example, different formulations of itraconazole have different food and absorption requirements. Other antifungals may have important interactions with medicines that affect stomach acidity.

When starting or changing treatment, ask your pharmacist:

  • Should I take this medicine with food or on an empty stomach?
  • Are there foods, supplements or other medicines I should avoid?
  • What should I do if I forget a dose?
  • What side effects should I report promptly?
  • Will I need blood tests or antifungal drug-level monitoring?

Do not assume that instructions for one antifungal apply to another, or even to a different formulation of the same drug.

4. Be especially careful about drug interactions

Azole antifungals, including itraconazole, voriconazole, posaconazole and isavuconazole, can interact with a wide range of other medicines.

Interactions may increase the risk of side effects, reduce the effectiveness of treatment or alter the amount of a medicine in your bloodstream.

Particularly important examples include some inhaled corticosteroids, certain cholesterol-lowering medicines, heart medicines and treatments that affect blood clotting.

Before starting any new medicine, including something bought from a pharmacy, tell the prescriber or pharmacist which antifungal you are taking.

This also applies when a medicine is stopped or its dose is changed.

Read more in our guide to antifungal drug interactions.

5. Never change corticosteroid treatment without advice

Some people with ABPA require oral corticosteroids, such as prednisolone or an alternative, to control inflammation. Others use inhaled corticosteroids for asthma or related conditions.

Long-term or repeated corticosteroid treatment can suppress the body's normal production of cortisol. This is known as adrenal suppression and can sometimes lead to adrenal insufficiency.

Stopping or reducing corticosteroids too quickly can be dangerous, particularly when adrenal function has been suppressed.

If you are taking long-term steroids:

  • Follow your prescribed dose and reduction schedule.
  • Do not stop treatment suddenly unless your clinical team specifically instructs you to do so.
  • Ask whether you need a steroid emergency card.
  • Understand what to do if you become acutely unwell, vomit or cannot keep medicines down.
  • Check whether you need an individualised sick-day or emergency steroid plan.

Important: People with known adrenal insufficiency may require additional steroid treatment during illness or other significant physical stress. Follow your own endocrine team's emergency instructions. Suspected adrenal crisis is a medical emergency.

6. Keep track of blood tests and monitoring

Some antifungal treatments require regular monitoring to check safety and ensure that the medicine is reaching an appropriate concentration in the body.

Depending on the treatment, monitoring may include:

  • Liver function tests.
  • Kidney function and electrolyte tests.
  • Antifungal drug levels (therapeutic drug monitoring).
  • Other tests related to the particular medicine or your health conditions.

Ask your specialist team which tests you need, how often they should be performed and who will review the results.

It can be helpful to record the dates of blood tests and follow-up appointments in your calendar.

If an expected result or appointment has not been communicated, contact the responsible clinical team rather than assuming everything is normal.

For more information, see antifungal medicines: dosing, monitoring and specialist care.

7. Recognise and report side effects

Many medicines have side effects, but not every new symptom is necessarily caused by treatment.

Commonly reported problems during antifungal treatment can include nausea, abdominal discomfort, changes in taste, headaches or skin reactions. The pattern varies between medicines.

Some adverse effects can be serious, including liver injury, significant drug interactions, heart rhythm problems or severe allergic reactions.

Contact your clinical team if you develop new or worsening symptoms that might be related to your medicines. Seek urgent medical advice for concerning symptoms such as jaundice, severe or persistent vomiting, fainting or a significant new rash. Severe breathing difficulty, collapse or swelling of the tongue or throat requires emergency assistance.

Do not simply tolerate troublesome side effects for weeks without discussing them. Your team may be able to adjust treatment, investigate another cause or consider an alternative medicine.

Equally, do not stop essential treatment on your own unless you have been instructed to do so or are following emergency advice for a suspected serious reaction.

8. What if you miss a dose?

Missing an occasional dose can happen, especially when you are unwell or your routine changes.

The correct response depends on the medicine, formulation and how long ago the dose was due.

Do not automatically take a double dose to make up for a missed one.

Check the patient information leaflet or ask your pharmacist or prescribing team for medicine-specific instructions.

If you repeatedly miss doses, explain this to your healthcare team. A simpler schedule, reminders or additional support may help.

9. Prepare for hospital admissions and changes in treatment

Medication errors can occur when care moves between hospital, GP services and specialist clinics.

Take your current medication list to appointments and hospital admissions, together with information about allergies, steroid dependency and any specialist treatment plans.

When leaving hospital, check:

  • Which medicines have changed?
  • Which medicines should be stopped?
  • Have any doses been altered?
  • Who will prescribe ongoing supplies?
  • Who is responsible for blood tests and follow-up?

Ask for clarification if the discharge medication list differs from your usual prescription.

It is particularly important that changes involving antifungals, corticosteroids and medicines with significant interactions are communicated clearly between teams.

10. Ask for help if managing medicines becomes difficult

Fatigue, breathlessness, poor concentration, visual difficulties or problems with hand movement can make medication management more demanding.

You do not have to manage everything without support.

Community pharmacists can advise on reminder systems, accessible packaging, medicine reviews and suitable aids. Family members or carers may also help, with your agreement.

If you take several medicines, ask whether a structured medication review would be appropriate.

Read our guide to aspergillosis medicines for carers.

Questions to ask at your next appointment

  • Do I still need every medicine on my list?
  • Are there any important interactions between my treatments?
  • Am I taking each medicine at the correct time and in the correct way?
  • What monitoring do I need, and who checks the results?
  • Which side effects should prompt me to contact the team?
  • What should I do if I miss a dose or cannot take my medicines?
  • Who should I contact if I have a medication problem between appointments?

Key points

  • Keep an accurate, up-to-date list of everything you take.
  • Follow medicine-specific instructions, especially for antifungals.
  • Check for interactions whenever medicines are started, stopped or changed.
  • Never change long-term corticosteroids independently without an appropriate clinical plan.
  • Keep track of monitoring and follow up missing results.
  • Report side effects rather than struggling with them in silence.
  • Ask for practical support when managing medicines becomes difficult.

Managing aspergillosis treatment safely is a shared responsibility between patients, pharmacists, GPs and specialist teams. Good communication and a few reliable routines can make long-term treatment easier and safer.

This article provides general patient information and does not replace individual advice from your prescribing clinician or pharmacist.


Chart showing quality-of-life concerns reported by 104 people with allergic bronchopulmonary aspergillosis (ABPA) in a 2021 patient-community survey.

What Worries People with ABPA Most? 104 Patients Tell Us

Living with ABPA: What matters most to patients?

Allergic bronchopulmonary aspergillosis (ABPA) is a complex lung condition that can affect much more than breathing. People living with ABPA may experience persistent tiredness, coughing, breathlessness and difficulty maintaining their usual activities. Treatments can also create challenges of their own.

But which of these problems concern patients the most?

In October 2021, members of an online aspergillosis patient community were invited to share the aspects of their quality of life that they most wanted to improve. A total of 104 people with ABPA responded.

Their answers provide a useful insight into the everyday challenges of living with ABPA and why understanding patients' priorities matters alongside clinical measurements and treatment decisions.

What did patients tell us?

The three most frequently reported concerns were:

  • Fatigue: feeling exhausted or lacking the energy needed for everyday activities.
  • Breathlessness: difficulty breathing during physical activity or sometimes even during ordinary daily tasks.
  • Coughing: a persistent or troublesome cough that can interfere with sleep, conversation and social activities.

Some respondents selected as many as 16 different concerns, illustrating how ABPA can affect several aspects of life simultaneously.

The original survey chart is reproduced below to preserve the patient-reported findings.

Chart showing quality-of-life concerns reported by 104 people with allergic bronchopulmonary aspergillosis (ABPA) in a 2021 patient-community survey.
Quality-of-life concerns reported by 104 people living with ABPA in an October 2021 patient-community survey.

Fatigue: More than simply feeling tired

Fatigue can be one of the most difficult symptoms of a long-term respiratory condition to explain to other people. It may involve physical exhaustion, difficulty concentrating and needing longer periods of recovery after activities that previously seemed straightforward.

In people with ABPA, fatigue may have several contributing factors, including ongoing respiratory symptoms, disturbed sleep, inflammation, other medical conditions and the effects of treatment.

Patients may find it helpful to discuss persistent fatigue with their clinical team rather than assuming that it is an unavoidable part of their condition. Some contributing problems may be treatable.

Read more about managing fatigue and energy with aspergillosis.

Breathlessness and loss of confidence

Breathlessness can make ordinary activities increasingly demanding. Walking, climbing stairs, shopping or doing housework may require more effort and more frequent rests.

It can also affect confidence. Some people begin avoiding activities because they worry about becoming breathless, which may contribute to physical deconditioning over time.

Appropriate treatment of the underlying lung disease is important, but patients may also benefit from individually tailored exercise, breathing techniques, pacing and pulmonary rehabilitation.

Read our guide to breathlessness and exercise with aspergillosis.

Living with a persistent cough

Coughing is another important concern for people with ABPA. It may be associated with airway inflammation, mucus production, asthma or coexisting bronchiectasis.

A persistent cough can be exhausting, disrupt sleep and make people uncomfortable in public or social situations.

Patients should tell their clinical team if their cough changes significantly, becomes more troublesome or is accompanied by new symptoms. Changes may require assessment rather than simply being attributed to established ABPA.

Airway clearance techniques may help some people who have difficulty clearing mucus, particularly those with bronchiectasis. These should be discussed with an appropriately trained respiratory physiotherapist.

Many problems can occur together

One striking feature of the survey was that some participants reported numerous concerns rather than one dominant symptom.

This reflects an important aspect of living with a chronic respiratory condition: symptoms can interact.

For example, coughing may disturb sleep, poor sleep may worsen fatigue, and fatigue may make physical activity more difficult. Reduced activity can then contribute to loss of fitness and greater breathlessness.

Recognising these connections may help patients and clinicians identify practical improvements even when the underlying lung condition cannot be completely resolved.

Why patient priorities matter

Clinical teams monitor ABPA using several measures, which may include symptoms, lung function, blood tests and chest imaging. These are important for assessing disease activity and treatment response.

However, improvements in clinical measurements do not always mean that a patient feels substantially better in everyday life.

Someone may have improved blood results but still struggle with fatigue, disrupted sleep or limited physical activity.

Asking patients what they most want to improve can help clinical teams focus on outcomes that are meaningful to them.

Patients may find it useful to prepare for appointments by identifying their two or three biggest difficulties and explaining how these affect everyday life.

What are the limitations of this survey?

This was an informal online patient-community poll conducted in October 2021, involving 104 respondents who identified as having ABPA.

Participation was voluntary, and respondents were drawn from an online support community. People experiencing more severe symptoms or particular concerns may have been more likely to participate.

Consequently, the findings should not be interpreted as showing how common individual symptoms are among all people with ABPA.

The survey was not designed to establish causes of symptoms, assess treatments or compare different patient populations.

Nevertheless, it provides a valuable record of the concerns that these patients chose to highlight.

What can we learn from patients' experiences?

The message from this survey is straightforward: people living with ABPA are concerned not only about controlling their disease but also about maintaining their energy, breathing comfortably and managing everyday activities.

Fatigue, breathlessness and coughing deserve attention because they can substantially affect quality of life, even when they are not the primary measures used to assess treatment response.

Listening to patients' priorities is an important part of delivering effective, compassionate respiratory care.

Further information and support

Patient Voices preserves the experiences and priorities shared by members of our aspergillosis community. These accounts complement, but do not replace, clinical research and individual medical advice.


Woman discussing her worries with a supportive healthcare professional.

Anxiety and Aspergillosis: Understanding the Impact on Mental Health

Woman discussing her worries with a supportive healthcare professional.
Talking about anxiety and emotional wellbeing can help people living with aspergillosis.

Living with aspergillosis can affect much more than your lungs. Anxiety, uncertainty, low mood, frustration and exhaustion are common experiences for people living with long-term health conditions. These feelings can affect everyday life, relationships, sleep and confidence.

It is important to understand that anxiety is not a sign of weakness, and it does not mean your physical symptoms are imaginary. Learning to recognise and manage anxiety can make living with aspergillosis easier, even when the underlying lung condition remains unchanged.

Why can aspergillosis cause anxiety?

People living with aspergillosis may experience anxiety for many reasons, including:

  • Breathlessness, coughing and unpredictable symptoms.
  • Worries about infections, flare-ups or disease progression.
  • Waiting for test results, scans or medical appointments.
  • Concerns about medication side effects and treatment decisions.
  • Changes to employment, independence or family responsibilities.
  • Feeling that other people do not understand the condition.
  • Uncertainty about what the future may hold.

Sometimes anxiety has an obvious cause. At other times, it develops gradually and becomes part of everyday life without us recognising it.

How anxiety and physical symptoms interact

Anxiety activates the body's stress response. Breathing may become faster, muscles tense, the heart beats more quickly and our attention becomes focused on possible threats.

For someone who already has a respiratory condition, these changes can make breathlessness feel more frightening or difficult to manage. Breathlessness can then increase anxiety, creating a cycle in which each makes the other harder to cope with.

Importantly, anxiety does not mean that breathlessness or other symptoms are psychological. New or worsening respiratory symptoms still need appropriate medical assessment. They should never automatically be attributed to anxiety.

Can stress make allergies worse?

Stress and allergic disease can influence one another. Research suggests that psychological stress may affect immune signalling and the activity of cells involved in allergic inflammation, including mast cells.

However, this does not mean anxiety causes an Aspergillus allergy or that relaxation can replace treatment for allergic bronchopulmonary aspergillosis (ABPA).

Reducing stress may help some people manage their symptoms and their response to them, but allergic inflammation still requires appropriate medical treatment.

Recognising anxiety

Anxiety does not always feel like worry. It may appear as:

  • Difficulty relaxing or sleeping.
  • Feeling constantly alert or expecting something to go wrong.
  • Repeatedly checking symptoms or searching for reassurance.
  • Difficulty concentrating or making decisions.
  • Muscle tension, restlessness or irritability.
  • Avoiding activities or appointments because of fear.
  • Feeling overwhelmed by relatively small problems.

Some of these experiences can also have physical or medication-related causes. Discuss persistent or changing symptoms with your healthcare team rather than assuming anxiety is responsible.

Practical ways to manage anxiety

1. Recognise what triggers it

Notice whether anxiety increases before appointments, during changes in symptoms, when starting medication or after reading health information online. Understanding patterns can help you prepare for difficult situations.

2. Try gentle relaxation techniques

Muscle relaxation, mindfulness, grounding exercises and gentle breathing techniques may help reduce tension.

If you have significant breathlessness, avoid forcing deep breaths or following breathing exercises that make you uncomfortable. Ask your respiratory physiotherapist about techniques appropriate for your lung condition.

3. Prepare for medical appointments

Writing down your questions, symptoms and concerns beforehand can reduce uncertainty. Taking someone with you or asking for written information may also help.

4. Maintain manageable activities

Gentle exercise, social contact, hobbies and regular routines can support mental wellbeing. Adapt activities to your physical abilities rather than pushing through severe symptoms.

5. Talk to other people

Sharing experiences with family, friends or people who understand aspergillosis can reduce isolation. Peer support can be particularly valuable when living with an uncommon condition.

6. Seek professional support

Cognitive behavioural therapy (CBT) and other psychological therapies can help people manage anxiety, health-related fears and depression. Seeking support does not mean that your physical illness is being dismissed.

Depression and living with chronic illness

Low mood is understandable during difficult periods, but persistent depression deserves attention in its own right.

Warning signs can include losing interest in enjoyable activities, feeling hopeless, withdrawing from other people or struggling with everyday tasks.

Fatigue, poor sleep and difficulty concentrating can arise from aspergillosis, medication effects or depression, sometimes in combination. Your GP or healthcare team can help assess what is contributing.

Where to find support

Relaxation and wellbeing resources

These resources may provide additional ideas for managing stress and anxiety:

Some older downloadable resources may contain dated information. Use current NHS guidance when seeking healthcare or psychological support.

When to seek help

Speak to your GP or healthcare team if anxiety or low mood is interfering with sleep, relationships, treatment or everyday activities, or if you feel unable to cope.

Seek urgent medical assessment for new or severe breathlessness, chest pain, significant bleeding or other potentially serious physical symptoms. Do not assume these are caused by anxiety.

If you need urgent mental health support in England, contact NHS 111 and select the mental health option. If someone is in immediate danger, call 999.

A final thought

Living with aspergillosis can be difficult and unpredictable. We cannot always control our symptoms, treatment outcomes or circumstances, but we can develop ways to manage the uncertainty surrounding them.

Reducing anxiety will not cure aspergillosis. It can, however, make a meaningful difference to confidence, wellbeing and quality of life.


Two empty chairs overlooking a peaceful landscape, symbolising reflection and conversations about future care.

Preparing for the End of Life: What Matters Most to You?

Two empty chairs overlooking a peaceful landscape, symbolising reflection and conversations about future care.
Planning ahead can help ensure that personal wishes are understood and respected.

Last reviewed: 9 October 2026

Most people living with aspergillosis are concentrating on living their lives, managing treatment and staying as well as possible. But serious or long-term illness can also prompt questions about the future, including what we would want if our health deteriorated.

For some people, these thoughts arise long before the end of life. Others prefer not to think about them until circumstances change. Both responses are understandable.

Talking about death does not mean giving up on life. It can be a way of making sure that, whatever happens, the people caring for us understand what matters most.

Key points

  • There is no single definition of a good death. Different people value different things.
  • Planning ahead can help patients retain influence over future care and make decisions easier for loved ones.
  • Palliative care can support quality of life alongside treatment and is not limited to the final days or weeks.
  • Advance statements, advance decisions, lasting powers of attorney and DNACPR decisions have different purposes.
  • Patients and carers can ask healthcare professionals for help with difficult conversations and planning.

What does a good death mean?

The expression "a good death" can sound strange. Death is something many people fear, and the experience of dying is not entirely within anyone's control.

Nevertheless, people often have clear ideas about what would make the end of their life more bearable, dignified or peaceful.

Some hope to remain at home. Others would feel safer in hospital or a hospice, with professional support close by. Some want family around them; others value privacy and quiet.

Common priorities include:

  • relief from pain, breathlessness and other distressing symptoms;
  • being treated with dignity and respect;
  • having personal wishes understood;
  • being able to spend time with important people;
  • receiving emotional, cultural or spiritual support where wanted;
  • avoiding treatments that would offer little benefit or cause unwanted burdens.

These are possibilities, not a checklist. A peaceful death does not require a particular setting, a particular belief, or a perfect set of family circumstances.

It is also important not to suggest that someone has failed if their death is difficult or does not happen as planned. Serious illness can be unpredictable, and even excellent care cannot guarantee a particular experience.

Understanding our fears

When people talk about being frightened of death, they may be describing several different fears.

Some fear the unknown. Others worry about pain, severe breathlessness, loss of independence, confusion, being alone, or leaving loved ones behind.

For people with advanced respiratory disease, the fear of struggling to breathe can be especially powerful.

These concerns deserve to be taken seriously. They should not be dismissed as simply anxiety or something that everyone must accept.

Healthcare professionals can often offer practical explanations about what symptoms might occur and how they would be managed. Understanding the options may reduce uncertainty, even when it cannot remove every fear.

Some people find comfort in religious or spiritual beliefs. Others draw strength from relationships, nature, music, personal memories or simply knowing that someone will listen. No particular belief is necessary to have a meaningful conversation about dying.

Thinking about what matters most

A useful starting point is not necessarily to ask, "How do I want to die?"

It may be easier to ask, "What makes life worth living for me, and what would I want people to understand if I became seriously unwell?"

Questions worth considering include:

  • What activities, relationships or experiences matter most to me?
  • What worries me most about becoming more unwell?
  • What would help me feel safe and comfortable?
  • Who would I want involved in discussions about my care?
  • Are there treatments or situations I would particularly want to discuss?
  • Would I prefer to receive care at home, in hospital or elsewhere, if circumstances allowed?
  • Are there religious, cultural or personal wishes that staff should know about?

There is no requirement to answer everything. Some people find it helpful to write down a few thoughts and return to them later.

Preferences may change as health, circumstances and understanding change. Planning ahead is an ongoing conversation, not necessarily a single decision.

Planning ahead for future care

Advance care planning is the process of discussing and recording wishes and priorities for future care, particularly in case a person becomes unable to make or communicate decisions.

Several different arrangements are available in England and Wales. They are related, but they are not interchangeable.

Advance statement

An advance statement records personal wishes, values and preferences. It might describe where you would prefer to receive care, what makes you comfortable, or who you would like involved.

An advance statement is not legally binding, but it should be taken into account when decisions are made about your care.

Advance decision to refuse treatment (ADRT)

An advance decision allows an adult with the necessary mental capacity to refuse specified medical treatments in defined future circumstances.

In England and Wales, an advance decision can be legally binding if it is valid and applicable to the situation.

Additional formal requirements apply when refusing life-sustaining treatment. These include putting the decision in writing, signing it, having it witnessed and clearly stating that it applies even if life is at risk.

This is an important decision to discuss with an appropriately qualified healthcare professional, particularly if you are considering treatments such as ventilation or resuscitation.

Lasting power of attorney for health and welfare

A health and welfare lasting power of attorney allows you to appoint someone you trust to make certain health and care decisions on your behalf if you lose the capacity to make those decisions yourself.

It must be registered before it can be used. Decisions about life-sustaining treatment require specific authority within the document.

Legal arrangements differ in Scotland and Northern Ireland, so patients living there should seek guidance relevant to their jurisdiction.

DNACPR decisions

DNACPR means Do Not Attempt Cardiopulmonary Resuscitation. It concerns whether CPR should be attempted if the heart or breathing stops.

A DNACPR decision does not mean that other treatment or care should stop. It does not automatically prevent antibiotics, oxygen, symptom relief, hospital admission or other appropriate treatment.

Decisions about CPR should involve appropriate discussion with the patient wherever possible. They should reflect clinical circumstances and the person's wishes and rights.

If you are worried about a DNACPR decision or do not understand why one has been proposed, ask your healthcare team to explain it.

Remember: while you have the capacity to make a particular decision, your own informed choices remain central. Advance planning becomes especially important if you later cannot make or communicate those choices.

Talking with family and healthcare professionals

Conversations about dying are not always easy. Families sometimes avoid the subject because they do not want to upset one another.

Yet uncertainty can also be distressing. Loved ones may worry about making the wrong decision if they do not know what the patient would have wanted.

You do not have to begin with a formal discussion about end-of-life care. You might simply say:

"I've been thinking about what would matter to me if I became much more unwell. I'd like us to talk about it sometime."

Or:

"I'm not expecting anything to happen soon, but I would feel better knowing you understood my wishes."

Not everyone will feel ready to talk. It may help to choose a quiet time, keep the conversation short and return to it later.

A GP, specialist nurse, respiratory consultant or palliative care professional can help explain the medical options and support conversations with family members.

Where wishes have been formally recorded, ask how they can be made available to the relevant healthcare services, including out-of-hours teams and emergency care.

Comfort, dignity and symptom control

Many people worry that dying from lung disease must involve severe breathlessness or distress.

Advanced respiratory illness can certainly cause difficult symptoms, but there are treatments and supportive approaches that may help.

Depending on the person's needs, care may include:

  • medication and other measures to relieve breathlessness or pain;
  • treatment of anxiety or agitation;
  • comfortable positioning and appropriate nursing care;
  • support with troublesome secretions, cough or other symptoms;
  • emotional, psychological or spiritual support;
  • specialist palliative care advice when symptoms are complex.

Some symptoms can be difficult to control completely, but patients and families should know that relief of suffering is an important part of medical care.

Palliative care is not restricted to the final stage of life. It can be provided alongside treatment for aspergillosis and other conditions, sometimes over an extended period.

Read our related article: Living Well with Aspergillosis: Understanding Palliative and Supportive Care.

Practical preparations

Some people find reassurance in organising practical matters while they are well enough to do so.

These might include:

  • making or reviewing a will;
  • recording important contacts and information about finances or household responsibilities;
  • considering who could manage practical affairs if needed;
  • writing down funeral or memorial preferences;
  • making sure trusted people know where important documents are kept;
  • recording personal messages or memories, if that feels meaningful.

These tasks are optional. They do not have to be completed all at once, and they are not a measure of how well someone has prepared.

Practical arrangements such as wills and powers of attorney may require independent legal advice.

Support for carers and families

Partners, relatives and friends may be deeply involved in caring for someone with advanced illness. They may help with medication, appointments, personal care, mobility, emotional support and communication with professionals.

They may also be frightened, exhausted or uncertain about what to do.

Carers can help by listening to the patient's wishes, supporting conversations and ensuring that healthcare professionals know about relevant plans. But they should not be expected to carry the entire responsibility for complex medical decisions.

It is important to remember that a family member does not automatically have legal authority to make healthcare decisions simply because they are the person's next of kin.

Carers also need support themselves. This may include:

  • clear information about the person's condition and care;
  • advice about what to do if symptoms worsen;
  • access to community nursing or specialist services where appropriate;
  • practical assistance and respite care;
  • emotional support before and after a bereavement.

There is no single correct way to be a carer. Being present, listening and asking for help when needed can be as important as providing practical care.

Living fully while planning ahead

Thinking about death need not mean spending every day anticipating it.

For many people, making some decisions in advance allows them to return their attention to the present: relationships, ordinary routines, enjoyable activities and the things that still give life meaning.

Some people want detailed plans. Others prefer to make only a few essential decisions. Both approaches can be reasonable.

The purpose is not to achieve a perfect death. It is to give people the greatest possible opportunity to be heard, respected and cared for according to what matters to them.

Further information and support

If you would like to discuss future care, you can start with your GP, respiratory team or specialist nurse. You do not need to wait until you are approaching the end of life to ask questions.

Author and review information

Author: Aspergillosis Website Editorial Team

Audience: Patients, carers and families

Last reviewed: 9 October 2026

Scope: General patient information. Legal explanations primarily concern England and Wales. Individual medical and legal decisions require appropriate professional advice.


Older patient discussing changes in his symptoms with a doctor during a GP consultation.

Don't Assume Every New Symptom Is Aspergillosis

Older patient discussing changes in his symptoms with a doctor during a GP consultation.
If you have aspergillosis, new or changing symptoms should not automatically be attributed to your existing condition.

When you live with a long-term illness such as aspergillosis, it is easy to assume that every new symptom is part of the condition you already have. But sometimes a new symptom has a different cause, and recognising that possibility can make an important difference.

This subject was originally discussed at a National Aspergillosis Centre patient meeting, prompted by concerns about delayed cancer diagnoses and the importance of recognising symptoms early.

The message remains relevant today: having one serious illness does not prevent us from developing another.

Why chronic illness can make new symptoms harder to recognise

People with aspergillosis may already experience coughing, breathlessness, fatigue, chest discomfort and changes in appetite or weight.

These symptoms can fluctuate. Patients become familiar with managing them, and sometimes learn to tolerate changes that would previously have prompted a visit to their GP.

This creates a risk known as diagnostic overshadowing: new symptoms may be attributed to an existing diagnosis without sufficient consideration of other explanations.

Patients can make this assumption, but healthcare professionals can do so too.

A change in symptoms might reflect worsening aspergillosis, but it could also result from a bacterial infection, another respiratory condition, a medication side effect, heart disease or an unrelated illness.

Occasionally, it may be a sign of cancer.

Why early recognition matters

Many illnesses, including several types of cancer, are easier to treat when identified earlier.

Early diagnosis does not guarantee a particular outcome, but it can provide more treatment options and reduce the risk of complications.

This does not mean that every new symptom is serious. Most symptoms have causes other than cancer.

The important principle is to notice persistent or unexplained changes and seek appropriate assessment rather than automatically attributing them to aspergillosis.

Changes that deserve attention

Symptoms worth discussing with your GP or specialist include:

  • A persistent change in your usual cough.
  • Breathlessness that is noticeably worse or different from normal.
  • Unexplained weight loss or loss of appetite.
  • Persistent or unexplained pain.
  • New lumps or swellings.
  • Blood in your urine or stools.
  • A persistent change in bowel habits.
  • Unusual bleeding.
  • New or changing skin lesions.
  • Fatigue that is significantly different from your usual pattern.

These symptoms do not necessarily indicate cancer. They can have many explanations, including treatable conditions.

However, they should not automatically be dismissed because you already have a chronic illness.

Lung cancer and aspergillosis: overlapping symptoms

Lung cancer and pulmonary aspergillosis can sometimes produce similar symptoms, including coughing, breathlessness, chest pain, coughing up blood and weight loss.

Both can also cause abnormalities on chest imaging.

This does not mean that aspergillosis inevitably increases someone's risk of lung cancer. Many patients have other risk factors or pre-existing lung conditions that need to be considered individually.

When symptoms or scans change unexpectedly, clinicians may need to investigate whether aspergillosis has progressed or whether another condition is responsible.

Read more in our article: Lung Cancer and Aspergillosis: When Symptoms and Scan Changes Need Careful Assessment.

Could medication be responsible?

Some medicines used to treat aspergillosis can produce symptoms that resemble other illnesses.

For example, antifungal medicines can affect liver function, cause gastrointestinal symptoms or interact with other medications.

One antifungal, voriconazole, is particularly associated with photosensitivity. Prolonged treatment has also been linked to an increased risk of certain skin cancers, especially squamous cell carcinoma.

This risk should not be generalised to every antifungal medicine.

Patients taking voriconazole should follow their clinical team's advice about sun protection and report new or changing skin lesions.

Importantly, suspected side effects should be assessed rather than assumed to explain every new symptom.

Don't forget routine screening

Living with a chronic respiratory condition should not mean missing routine NHS screening invitations.

Depending on your age, sex and eligibility, you may be invited for screening programmes such as:

  • Bowel cancer screening.
  • Breast screening.
  • Cervical screening.
  • Lung cancer screening for eligible people in the relevant age and smoking-risk groups.

Screening is intended for people who do not necessarily have symptoms. If you develop a concerning symptom, contact your GP rather than waiting for your next screening invitation.

Screening eligibility and arrangements can change, so consult the NHS screening information for current guidance.

What should you say to your GP?

Patients sometimes worry that they will be seen as overreacting, particularly when they already have frequent medical appointments.

It can help to explain exactly what has changed.

For example:

"I have aspergillosis and I am used to coughing and feeling tired, but this symptom is different from my normal pattern. I would like to make sure there isn't another cause."

Try to describe:

  • When the change began.
  • Whether it is persistent or getting worse.
  • How it differs from your usual symptoms.
  • Whether it affects sleep, appetite, activity or daily life.
  • Any other new symptoms occurring at the same time.

A brief symptom diary can be useful, especially when changes develop gradually.

When should you seek urgent help?

Some symptoms need urgent assessment rather than a routine appointment.

Call 999 for severe breathing difficulty, severe chest pain or coughing up significant amounts of blood, particularly if accompanied by breathlessness, dizziness or feeling faint.

For other urgent concerns that cannot wait for a routine GP appointment, contact NHS 111 or an appropriate urgent care service.

The importance of looking beyond one diagnosis

Living with aspergillosis often means becoming highly knowledgeable about your own symptoms and treatment.

That experience is valuable. You may be the first person to notice when something has changed.

But familiarity can also make unusual symptoms seem normal.

The key message is simple: having aspergillosis does not mean that everything that happens to your health is caused by aspergillosis.

Recognising a change and asking for it to be investigated is not being unnecessarily anxious. It is an important part of looking after your health.

Further information

Last reviewed: October 2026. This article provides general patient information and does not replace individual medical advice.


Medical illustration showing Aspergillus spores entering the lungs, triggering an IgE-mediated allergic response and airway inflammation.

What is an allergy?

Medical illustration showing Aspergillus spores entering the lungs, triggering an IgE-mediated allergic response and airway inflammation.
Aspergillus spores can trigger an allergic immune response in susceptible people, contributing to conditions such as ABPA and fungal-sensitised asthma.

What happens when we develop an allergy, and why can a common fungus such as Aspergillus cause serious respiratory symptoms in some people but not others?

Allergies occur when the immune system reacts to something that is usually harmless. These substances are called allergens. Common examples include pollen, house dust mites, animal dander and fungal spores.

Most people breathe in Aspergillus spores every day without becoming ill. However, in some people, particularly those with asthma or certain other respiratory conditions, the immune system develops an exaggerated response.

Understanding this response helps explain conditions such as allergic asthma, fungal sensitisation and allergic bronchopulmonary aspergillosis (ABPA).

What is an allergy?

Our immune system protects us against infections and other threats. It recognises substances entering the body and decides whether a response is needed.

In an allergy, the immune system mistakenly treats a normally harmless substance as a threat.

This can trigger inflammation and symptoms such as:

  • Sneezing, a runny nose or nasal congestion.
  • Itchy, watery eyes.
  • Coughing, wheezing or breathlessness.
  • Skin irritation, itching or hives.
  • Occasionally, severe allergic reactions affecting several parts of the body.

Not all allergic reactions involve the same immune mechanisms. Different types of allergy can affect different organs and produce different patterns of symptoms.

What happens inside the immune system?

One important form of allergy involves an antibody called immunoglobulin E (IgE).

When someone becomes sensitised to an allergen, their immune system may produce IgE antibodies that recognise it.

These antibodies can attach to immune cells called mast cells. When the allergen is encountered again, it can trigger the release of substances including histamine and other inflammatory mediators.

These substances contribute to swelling, mucus production, itching and narrowing of the airways.

In respiratory allergy, other immune cells, including eosinophils, may also contribute to inflammation.

However, having allergen-specific IgE antibodies does not necessarily mean that a person has symptoms or an allergic disease requiring treatment. This distinction is particularly important when interpreting Aspergillus blood tests.

What is Aspergillus?

Aspergillus is a group of fungi found widely in the environment. Its spores are present in outdoor air, soil, decaying vegetation and sometimes indoor environments.

Aspergillus fumigatus is one of the species most frequently associated with human respiratory disease.

Breathing in Aspergillus spores is a normal part of everyday life. Healthy lungs and immune defences usually remove them without difficulty.

Problems can arise when someone develops an allergic response, when the fungus persists in already damaged airways, or when the immune system cannot adequately control fungal growth.

These situations can produce different diseases and require different treatments.

What does Aspergillus sensitisation mean?

Aspergillus sensitisation means that the immune system has developed an allergic response to Aspergillus, usually demonstrated by a positive specific IgE blood test or skin-prick test.

Sensitisation does not automatically mean that someone has ABPA or an Aspergillus infection.

Some people with asthma are sensitised to Aspergillus and may experience worsening respiratory symptoms when exposed to fungal allergens.

Others have a positive test without clear symptoms attributable to Aspergillus.

Doctors interpret these results alongside symptoms, medical history, lung function and other investigations.

How is ABPA different from an ordinary allergy?

Allergic bronchopulmonary aspergillosis (ABPA) is a more complex allergic and inflammatory condition, most often associated with asthma or cystic fibrosis. It can also occur in some people with bronchiectasis or other pre-existing respiratory conditions.

In ABPA, Aspergillus may persist within the airways and provoke a substantial immune response.

This can cause:

  • Worsening asthma symptoms or breathlessness.
  • Persistent coughing and mucus production.
  • Thick mucus plugs, sometimes brownish in colour.
  • Inflammation and changes visible on chest scans.
  • Elevated total IgE and other evidence of an allergic response.
  • In some patients, bronchiectasis or additional lung damage over time.

ABPA is not the same as invasive aspergillosis, in which fungal growth invades tissues. Nor is it simply an ordinary seasonal allergy.

Because ABPA involves several immune pathways, diagnosis requires more than a single positive allergy test.

Treatment may involve corticosteroids to control inflammation, antifungal medicines to reduce fungal burden, and in selected cases biological therapies targeting specific inflammatory pathways.

The appropriate treatment depends on disease activity, previous treatment, other health conditions and individual risks.

What is severe asthma with fungal sensitisation?

Some people with severe asthma are sensitised to fungi, including Aspergillus, but do not meet the diagnostic criteria for ABPA.

This has sometimes been described as severe asthma with fungal sensitisation (SAFS).

Fungal sensitisation may be associated with more difficult-to-control asthma, although it is not always possible to establish how much of an individual's symptoms are caused by the fungus itself.

Management focuses on optimising asthma treatment, assessing the contribution of fungal allergy and considering additional therapies when appropriate.

SAFS and ABPA are related concepts, but they should not be treated as interchangeable diagnoses.

Is fungal allergy the same as a fungal infection?

No. This is one of the most important distinctions.

Allergy describes an inappropriate or exaggerated immune response to fungal allergens.

Infection involves fungal growth causing disease in the body.

Some conditions, including ABPA, involve both fungal persistence in the airways and an exaggerated immune response. However, the disease mechanism is primarily allergic and inflammatory rather than tissue-invasive infection.

Chronic pulmonary aspergillosis (CPA), by contrast, is a long-term fungal infection usually associated with existing lung damage.

Different forms of aspergillosis can occasionally coexist, making specialist assessment important.

What about hypersensitivity pneumonitis?

Hypersensitivity pneumonitis is another immune-mediated lung disease that can be triggered by inhaled environmental substances, including some fungal antigens.

It is sometimes called extrinsic allergic alveolitis.

Despite the word "allergic" in its older name, hypersensitivity pneumonitis is not simply an IgE-mediated allergy.

It involves immune reactions affecting the small airways and lung tissue. Repeated exposure to a relevant trigger can cause inflammation and, in some cases, progressive lung scarring.

Diagnosis and treatment differ from those used for ABPA. Identifying and reducing exposure to the responsible antigen is often an important part of management.

How do doctors investigate Aspergillus allergy?

Depending on symptoms and the suspected diagnosis, investigations may include:

  • Aspergillus-specific IgE: Looks for evidence of allergic sensitisation.
  • Total IgE: Measures overall IgE levels and can help assess ABPA alongside other findings.
  • Blood eosinophil count: May provide information about allergic or type 2 inflammation.
  • Aspergillus-specific IgG: Can support assessment of certain Aspergillus-related conditions, but is not itself a test for IgE-mediated allergy.
  • Chest CT: May identify bronchiectasis, mucus plugging or other lung abnormalities.
  • Lung function tests: Assess airflow limitation and changes in respiratory function.
  • Sputum testing: May identify Aspergillus or other organisms in respiratory samples.

Each test answers a different question. A diagnosis should not be based on one abnormal result alone.

Should I avoid Aspergillus spores?

It is impossible to avoid Aspergillus completely because its spores are widespread in the environment.

For most people, ordinary outdoor activities are not a reason for concern. However, some activities can generate unusually high concentrations of fungal spores.

These may include:

  • Turning compost or handling mouldy, decomposing vegetation.
  • Disturbing large amounts of damp or mouldy material.
  • Cleaning heavily contaminated indoor spaces.
  • Working in dusty environments containing organic material.

People with ABPA, severe fungal sensitisation or significant immune suppression may benefit from individual advice about higher-risk exposures.

This does not mean that everyone with Aspergillus allergy must stop gardening, avoid outdoor exercise or make major changes to everyday life.

Exposure reduction should be proportionate to the person's condition and circumstances.

Can Aspergillus allergy go away?

Allergic sensitisation can persist for many years, but symptoms and disease activity may change over time.

Some people experience long periods of good symptom control. Others have recurring episodes of inflammation or asthma exacerbations.

In ABPA, treatment can bring the disease into remission, although relapse remains possible.

It is therefore more useful to distinguish between sensitisation, symptoms and active disease than to assume that a positive allergy test means someone will always be unwell.

What can patients do?

  • Take prescribed asthma or ABPA treatment as directed.
  • Attend recommended monitoring appointments.
  • Discuss changes in symptoms with your clinical team.
  • Ask what your allergy blood tests actually mean.
  • Reduce exposure to obvious sources of heavy mould contamination where practical.
  • Avoid making major lifestyle restrictions without individual clinical advice.

If breathing symptoms worsen suddenly or become severe, seek urgent medical assessment rather than assuming they are caused by allergy alone.

The most important message

Being allergic or sensitised to Aspergillus is not the same as having aspergillosis.

Aspergillus can be associated with several different respiratory conditions, ranging from allergic sensitisation to ABPA and chronic or invasive fungal disease.

Understanding which condition is present helps patients and clinicians choose appropriate treatment, interpret test results and avoid unnecessary worry.

Further reading

Last reviewed: October 2026. This article provides general information and does not replace an individual clinical assessment.


Person walking along a countryside path towards the setting sun, overlooking green hills and a valley.

Living with Aspergillosis: What Is the Long-Term Outlook?

Person walking along a countryside path towards the setting sun, overlooking green hills and a valley.
Living with aspergillosis can involve uncertainty, but treatment and ongoing support can help many people maintain their quality of life.

What does an aspergillosis diagnosis mean for your future? It is one of the most understandable questions patients ask, particularly when they have been told they have a long-term lung condition.

The answer depends on the type of aspergillosis, the health of your lungs and immune system, and how well your condition responds to treatment. Some people recover completely. Others live with aspergillosis for many years, managing it as a chronic illness.

There is no single prognosis that applies to everyone with aspergillosis.

What does prognosis mean?

Prognosis means the likely course or outcome of a medical condition. It may include whether the disease is expected to improve, remain stable, return after treatment or progress over time.

Prognosis is not a prediction of exactly what will happen to an individual. Doctors use information from studies, scans, blood tests, lung function and treatment responses to make an informed assessment, but every patient's circumstances are different.

How does the outlook differ between types of aspergillosis?

Allergic bronchopulmonary aspergillosis (ABPA)

ABPA is an allergic and inflammatory reaction to Aspergillus, usually affecting people with asthma or cystic fibrosis. It is not the same as an invasive fungal infection.

Many people with ABPA respond well to treatment and experience long periods of stability or remission. However, ABPA can relapse, sometimes requiring further treatment.

Repeated or poorly controlled inflammation may contribute to permanent changes in the airways, including bronchiectasis. This is one reason why regular monitoring and appropriate treatment matter.

For many patients, the long-term aim is to control inflammation, prevent exacerbations, preserve lung function and minimise treatment side effects.

Chronic pulmonary aspergillosis (CPA)

CPA is a long-term fungal infection that usually develops in people whose lungs have already been damaged by another condition, such as tuberculosis, COPD or bronchiectasis.

Without effective treatment, some forms of CPA can progressively damage lung tissue. However, treatment can improve symptoms, stabilise disease and reduce the risk of further deterioration.

Many patients need antifungal treatment for months or years. Some require longer-term suppressive treatment to keep the infection under control.

The outlook varies considerably. Someone with a small, localised area of disease and otherwise good lung function may have a very different prognosis from someone with extensive lung damage and several additional health problems.

Some patients with a single aspergilloma or localised disease may be suitable for surgery, which can sometimes offer a lasting cure. Surgery is not appropriate for everyone.

Invasive aspergillosis

Invasive aspergillosis is a serious infection that usually occurs in people with significantly weakened immune systems or those who are critically ill.

It requires urgent specialist treatment, often in hospital. The outlook depends on how quickly treatment begins, the extent of infection, the underlying illness and whether immune function can recover.

It is important not to confuse the prognosis of invasive aspergillosis with that of ABPA or CPA. They are different conditions, affecting different patient groups.

What influences your individual outlook?

Several factors can affect how aspergillosis develops over time:

  • The type and extent of disease: Whether aspergillosis is allergic, chronic or invasive, and how much of the lungs is affected.
  • Existing lung health: Conditions such as bronchiectasis, COPD, asthma or previous lung infections can influence symptoms and recovery.
  • Immune function: Some illnesses and medicines make it harder for the body to control fungal infection.
  • Response to treatment: Effective treatment can improve symptoms and help prevent progression.
  • Treatment tolerance: Side effects, drug interactions and antifungal resistance can make treatment more complicated.
  • Other health conditions: Heart disease, nutritional problems, frailty and other illnesses may affect overall health and recovery.

Your clinical team considers these factors together rather than relying on any single test result.

Does long-term treatment mean the disease cannot improve?

No. Some conditions require ongoing treatment precisely because treatment is working.

For example, a patient with CPA may continue antifungal medication because it has stabilised their infection and reduced symptoms. Stopping treatment is not always appropriate simply because they feel better.

Equally, some people with ABPA achieve remission and may not need continuous treatment, although monitoring remains important.

The distinction between controlling a disease and curing it is useful. Successful treatment does not always mean that every abnormality on a scan disappears.

Can aspergillosis get worse after a period of stability?

Yes, although deterioration is not inevitable.

ABPA can flare after a period of remission. CPA may progress or relapse, including after antifungal treatment is stopped. Other respiratory problems, such as bacterial infections or worsening bronchiectasis, can also cause symptoms that resemble a change in aspergillosis.

A change in symptoms does not automatically mean that the fungal disease has progressed. It does mean that reassessment may be needed.

Contact your clinical team if you experience a sustained increase in breathlessness, cough, fatigue, sputum production, fever or unexplained weight loss.

Urgent symptoms: Coughing up more than a few streaks of blood, particularly with breathlessness, chest pain or dizziness, requires emergency assessment. Sudden severe breathlessness or other signs of serious illness also require urgent medical help.

How do doctors know whether treatment is working?

Monitoring usually involves a combination of:

  • Changes in symptoms and ability to manage everyday activities.
  • Chest CT scans or other imaging, when appropriate.
  • Blood tests, including Aspergillus antibodies or allergy markers relevant to the diagnosis.
  • Lung function measurements.
  • Sputum samples and other microbiological investigations.
  • Checks for medication side effects, interactions and antifungal drug levels where indicated.

No single measurement tells the whole story. A patient may feel better before substantial changes are visible on a scan, while persistent breathlessness may reflect existing lung damage rather than active fungal disease.

What about life expectancy?

It is natural to want a number, but published survival statistics can be difficult to interpret.

Studies may involve patients who are older, have extensive underlying lung disease or were treated before newer approaches became available. Their outcomes cannot automatically be applied to someone newly diagnosed today.

Survival figures also differ dramatically between ABPA, CPA and invasive aspergillosis.

For most patients, a more useful discussion with their specialist is:

  • Is my disease currently stable, improving or progressing?
  • What changes are visible on my scans?
  • How much of my breathlessness comes from aspergillosis and how much from other lung conditions?
  • What are we hoping treatment will achieve?
  • What signs would suggest that we need to change the treatment plan?
  • What can I realistically expect over the next year?

These questions can provide a clearer picture than a general statistic.

Living well with a long-term diagnosis

Prognosis is about more than survival. Patients are often equally concerned about independence, energy levels, work, relationships and whether they will still be able to enjoy the activities that matter to them.

Managing associated respiratory conditions, maintaining physical activity within individual limits, following airway clearance advice where appropriate, eating adequately and seeking support for emotional wellbeing can all contribute to quality of life.

For some patients, pulmonary rehabilitation or physiotherapy can help improve confidence and everyday functioning, even when underlying lung damage cannot be reversed.

It is also reasonable to discuss fatigue, anxiety, treatment burden and uncertainty with your clinical team. These are important parts of living with aspergillosis, not secondary concerns.

The most important message

An aspergillosis diagnosis does not come with a single predetermined future.

Some people recover, some achieve long periods of remission, and others need continuing treatment and support. The aim of specialist care is not simply to treat a fungus or improve a scan, but to protect lung function, manage symptoms and help people live as well as possible.

If you are worried about your prognosis, ask your specialist to explain what they know about your disease, what remains uncertain and what the treatment plan is intended to achieve.

Further reading

Last reviewed: October 2026. This article provides general patient information and cannot predict an individual's prognosis. Treatment decisions should be discussed with the healthcare professionals responsible for your care.


Online aspergillosis patient support group meeting, showing people connecting and sharing experiences through video chat.

Why can an hour spent talking to other people living with aspergillosis leave us feeling better, even when our physical symptoms haven't changed?

Online aspergillosis patient support group meeting, showing people connecting and sharing experiences through video chat.
Online patient support meetings help people living with aspergillosis share experiences, build friendships and feel less isolated.

Something interesting came up during one of our regular Thursday morning patient discussions.

Several people had joined the meeting feeling exhausted, unwell or emotionally drained. Yet afterwards, they described feeling noticeably better.

Their aspergillosis hadn't disappeared. Their medication hadn't changed. Their physical symptoms might have been much the same.

So what had changed?

We put this question to the group, and the subsequent conversation revealed something important about living with a chronic illness.

From seeking information to finding friendship

One of our long-standing members reflected on how her reasons for attending the meetings had changed over time.

Initially, she wanted information. She needed to understand aspergillosis, its treatments, its symptoms and what the future might hold.

But as the years passed, something else became increasingly important: the relationships she had developed with other members.

When someone is first diagnosed with aspergillosis, particularly a long-term condition such as chronic pulmonary aspergillosis (CPA) or allergic bronchopulmonary aspergillosis (ABPA), they often have many questions.

What does the diagnosis mean? Will treatment work? Why am I so tired? Is what I'm experiencing normal?

Information can help answer those questions. But information alone cannot necessarily address the isolation that comes with living with a condition that few people around you understand.

Over time, a support group can become something more than a source of information. It becomes a community.

Not having to explain yourself

One of the most revealing observations concerned the difference between talking to someone who has experienced chronic illness and someone who hasn't.

Friends and family generally want to help. But when we describe feeling exhausted, frightened or frustrated, they may feel obliged to offer reassurance, advice or a solution.

Sometimes we don't need any of those things.

We simply want to describe how we feel.

Among people who share similar experiences, there is often no need for lengthy explanations. Someone can say they've had a dreadful week, and others immediately understand.

Nobody has to solve the problem. Nobody has to offer sympathy. Sometimes being heard is enough.

There is a considerable difference between someone knowing that you are ill and someone understanding what living with that illness actually feels like.

The importance of feeling useful

Another theme emerged from the discussion. People don't simply feel better because they receive support. They may also benefit from offering it.

Living with chronic illness can take away many of the roles that previously gave life structure and meaning. Employment may become difficult. Social activities can become exhausting. Helping family and friends may no longer be possible in the same way.

Within a patient group, however, someone who is struggling physically may still have valuable experience to share.

A suggestion about managing fatigue, a reassuring account of a treatment experience or simply listening to someone having a difficult day can make a real difference.

The person offering that support may leave the meeting feeling that they have contributed something worthwhile.

Illness may limit what we can do physically, but it doesn't remove our ability to help others.

A safe place to be yourself

One member described the group as a safe harbour.

That phrase captures something important.

Living with a serious or unpredictable illness can create considerable uncertainty. There may be difficult test results, medication side effects, periods of deterioration and anxiety about the future.

In everyday life, people sometimes feel they must put on a brave face.

Within a trusted group, that pressure may be reduced.

Members can talk about difficult experiences without worrying that they are burdening others. They can also laugh, exchange ordinary news and enjoy conversations that have little to do with illness.

These relationships matter because they recognise the whole person, rather than defining someone entirely by their diagnosis.

What does the research tell us?

Research into peer support provides some evidence for the benefits that patients describe.

A 2025 systematic review published in Communications Psychology examined 100 papers investigating online support groups for people with chronic conditions.

The researchers identified several mechanisms through which these groups may help:

  • Exchanging support: receiving and offering practical or emotional encouragement.
  • Sharing experiences: recognising that others face similar difficulties.
  • Expressing feelings: having opportunities to discuss experiences openly.
  • Social comparison: learning from how others manage their conditions and circumstances.

The review suggested that online support groups can have positive effects on social wellbeing, behaviour and adjustment to illness.

However, evidence for improvements in physical health and overall quality of life was inconclusive. Some participants also experienced increased anxiety or distress after hearing about other people's difficult experiences.

This is an important distinction. Support groups are not a treatment for the underlying disease, and they cannot replace specialist medical care.

Nevertheless, the research helps explain why people may feel less isolated, better understood and more able to cope after participating.

Research: Mills F, Drury J, Hall CE, et al. (2025). A mixed studies systematic review on the health and wellbeing effects, and underlying mechanisms, of online support groups for chronic conditions. Communications Psychology, 3, 40.

Why might we feel better after a meeting?

Returning to our original question, several explanations seem possible.

  • We feel heard. We have been able to express feelings that might otherwise remain unspoken.
  • We feel less alone. Hearing others describe similar experiences reminds us that we aren't the only people facing these difficulties.
  • We gain perspective. Someone else's experience may help us understand our own situation differently, without dismissing its seriousness.
  • We feel useful. Offering encouragement or practical advice can restore a sense of purpose.
  • We enjoy human connection. Friendship, humour and familiar faces are valuable in their own right.

None of this means that our physical illness is imaginary or that positive thinking can cure aspergillosis.

It means that our emotional and social wellbeing are important parts of living with a long-term medical condition.

Sometimes, improving those aspects of life can make a difficult day feel a little easier.

Understanding the exhaustion of chronic illness

Another discussion among our members concerned the Spoon Theory, a way of describing the limited and fluctuating energy available to people living with chronic illness.

One member made an especially interesting observation: not only can the number of spoons change from day to day, but the size of the spoons can change too.

On some days, even a simple activity requires considerable effort. On others, we may have more energy available.

This helps explain why people may feel exhausted even when they have apparently done very little.

It also reminds us that emotional and social activities can require energy, although they may bring considerable enjoyment and encouragement in return.

For more practical information, see Managing Fatigue and Energy in Aspergillosis and Allergic Fungal Lung Disease.

The value of simply being there

One of the lessons from our Thursday discussions is that people don't always need a carefully planned programme or a formal educational presentation.

Sometimes the most valuable thing is simply having a regular opportunity to meet.

The conversation may begin with a question about medication, move to an experience in hospital and finish with laughter about something completely unrelated.

That is part of what makes these meetings worthwhile.

For some members, particularly those who are isolated by illness, these regular conversations may be among their most meaningful social contacts.

And importantly, there is no requirement to contribute. Listening can be just as valuable as speaking.

Join our Thursday patient discussions

The National Aspergillosis Centre holds informal online discussions every Thursday at 10 am UK time.

Patients, carers, relatives and supporters are welcome. You can share your experiences, ask questions or simply listen.

There is no pressure to speak, and no specialist knowledge is needed.

Find out more about the Thursday Sessions and how to join.

You may also enjoy reading Living with Aspergillosis: Managing Stress, Energy and Change, which explores balancing illness management with the parts of life that matter to us.

Further reading and resources

We'd like to hear your experiences

Have you ever felt better after talking to someone who understands your illness?

Is it the information, the reassurance, the friendships or simply the opportunity to talk openly that helps you most?

And if you've never attended a patient support meeting, is there something that makes you hesitant?

We would be interested to hear your thoughts and experiences.

This article was inspired by conversations among members of our aspergillosis patient support community. Their experiences are personal observations, not evidence that support meetings directly improve physical disease outcomes. Peer support complements, but does not replace, professional medical care.


Woman experiencing brain fog, with an illustration of the brain surrounded by mist, lungs and corticosteroid medication representing possible causes in aspergillosis.

Brain Fog in Aspergillosis: Why It Happens and What Might Help

Woman experiencing brain fog, with an illustration of the brain surrounded by mist, lungs and corticosteroid medication representing possible causes in aspergillosis.
Brain fog can affect memory, concentration and everyday life. In aspergillosis, infection, inflammation, corticosteroids and other factors may contribute.

Brain fog can make familiar tasks unexpectedly difficult, sometimes threatening a person's ability to work or manage everyday life. What causes it, why can corticosteroids sometimes make it better or worse, and what can patients do?

When thinking becomes difficult

During a recent patient discussion, a woman described how difficult it had become to continue working in a demanding environment while experiencing brain fog.

Her job requires her to remain on her feet, concentrate on proceedings and respond to what is happening around her. These are abilities she has relied upon throughout her working life. Yet she described how much harder they had become.

She believes her brain fog is associated with the oral corticosteroids she needs to take.

Her experience raises an important question: what happens when an illness, or the treatment needed to control it, interferes with the mental abilities someone depends upon to earn a living?

For many patients, brain fog is much more than occasional forgetfulness. It can undermine confidence, make ordinary conversations exhausting and turn familiar tasks into unexpected challenges.

And perhaps most frustratingly, it is a symptom that other people cannot easily see.

But what exactly is brain fog? Do we know what causes it? And, most importantly, can anything be done?

What is brain fog?

Brain fog is an informal term used to describe a collection of cognitive symptoms.

People commonly report:

  • Difficulty concentrating or maintaining attention.
  • Forgetting information they would normally remember.
  • Losing track of conversations or what they were doing.
  • Struggling to find familiar words.
  • Taking longer to understand or process information.
  • Feeling mentally exhausted after relatively simple tasks.
  • Difficulty planning, organising or making decisions.

Some patients describe it as trying to think through thick fog. Others say that their brain simply will not work at its usual speed.

Importantly, brain fog is not a diagnosis in itself. It describes an experience that may have several different underlying causes.

It is also not necessarily a sign of dementia or permanent brain damage.

Many people experience fluctuating symptoms, with periods of relatively clear thinking interrupted by episodes of cognitive difficulty.

That variability is scientifically interesting because it suggests that, in some cases, brain function is being temporarily disrupted rather than permanently lost.

Why might aspergillosis cause brain fog?

Brain fog is not usually included among the defining diagnostic symptoms of aspergillosis. Nevertheless, people with chronic pulmonary aspergillosis (CPA), allergic bronchopulmonary aspergillosis (ABPA) and other chronic respiratory illnesses may experience cognitive difficulties.

There are several plausible explanations, and more than one may be operating at the same time.

1. Inflammation and the immune system

When the body responds to infection or inflammation, immune cells release chemical messengers called cytokines.

These substances help coordinate the immune response, but inflammatory signalling can also affect the nervous system.

We are familiar with some of these effects during influenza or other infections: exhaustion, reduced concentration, loss of motivation and a strong desire to rest.

Researchers sometimes refer to this coordinated response as sickness behaviour.

It may be a useful short-term adaptation during illness, but persistent inflammatory activity could contribute to ongoing symptoms.

In CPA, chronic infection and inflammation may continue over long periods. In ABPA, allergic inflammation can fluctuate, sometimes becoming particularly active during exacerbations.

It is therefore biologically plausible that inflammation contributes to cognitive symptoms in some patients.

However, we do not yet have strong evidence identifying a specific inflammatory mechanism responsible for brain fog in aspergillosis.

2. Fatigue and reduced mental energy

Fatigue is a major problem for many people with chronic respiratory disease.

But fatigue is not always simply a feeling of sleepiness.

Patients may experience profound physical and mental exhaustion, even after relatively modest activity.

Thinking itself requires sustained effort. Concentrating, remembering information, making decisions and following conversations all depend on networks of brain activity.

When someone is already exhausted by illness, ordinary cognitive tasks may become much more demanding.

This can create a frustrating cycle: the more someone tries to concentrate, the more mentally exhausted they become.

3. Oxygen and carbon dioxide levels

The brain requires a continuous supply of oxygen.

Significant reductions in blood oxygen levels can affect concentration, alertness and cognitive performance.

In people with advanced respiratory disease, inadequate ventilation may also allow carbon dioxide to accumulate in the blood.

Raised carbon dioxide can cause headaches, drowsiness and confusion.

These problems are particularly important during respiratory deterioration.

However, it would be incorrect to assume that every patient experiencing brain fog has low oxygen levels. Many people report cognitive difficulties despite having satisfactory oxygen measurements.

A normal spot oxygen saturation reading also does not assess carbon dioxide levels or explain every possible cause of cognitive symptoms.

4. Poor sleep

Sleep disturbance is another potentially important contributor.

Persistent coughing, breathlessness, discomfort, anxiety and medication effects can all interfere with sleep.

Poor sleep affects attention, memory and the ability to process information.

A patient may therefore experience substantial brain fog even when their respiratory disease appears relatively stable.

Sleep apnoea and other sleep disorders can also contribute and may be worth investigating when symptoms suggest them.

The corticosteroid paradox: why can steroids make brain fog better or worse?

This is one of the most interesting questions raised by patients.

Some describe developing brain fog while taking oral corticosteroids.

Others report that their thinking becomes noticeably clearer after an increase in corticosteroid treatment.

How can the same type of medicine apparently produce opposite effects?

The answer is that corticosteroids influence several biological systems simultaneously.

Corticosteroids can reduce inflammation

Medicines such as prednisolone and methylprednisolone suppress inflammatory activity.

For someone experiencing an inflammatory exacerbation, effective treatment may improve symptoms, sleep and general wellbeing.

If inflammation or illness-related exhaustion is contributing to cognitive difficulties, improved disease control might also improve mental clarity.

However, an improvement after taking corticosteroids does not prove that brain inflammation was present.

Corticosteroids can also affect the brain directly

Glucocorticoid hormones influence brain regions involved in memory, attention, emotion and stress responses.

Excessive glucocorticoid exposure can produce insomnia, agitation, anxiety, mood changes and difficulties with concentration.

The effects depend on factors including dose, duration, individual susceptibility and the person's underlying health.

This means that a patient may experience worse cognitive symptoms even while their respiratory inflammation is improving.

What about adrenal insufficiency?

Cortisol is an essential hormone produced by the adrenal glands.

It helps regulate metabolism, blood pressure, stress responses and many other bodily functions.

Long-term corticosteroid treatment can suppress the body's own cortisol production. Some patients develop secondary or tertiary adrenal insufficiency.

When cortisol availability is inadequate, symptoms can include severe fatigue, weakness, dizziness, nausea and difficulty concentrating.

During infection or other physiological stress, the body's normal requirement for cortisol increases.

For someone with adrenal insufficiency, an appropriate increase in replacement treatment under their established sick-day plan may improve symptoms caused by inadequate cortisol availability.

This provides one possible explanation for reports of brain fog improving after a corticosteroid dose increase.

But it is important not to jump to conclusions.

An improvement following extra corticosteroid does not establish adrenal insufficiency, and increasing the dose is not a reliable treatment for brain fog in general.

Both insufficient and excessive glucocorticoid exposure can cause problems.

Patients should not change prescribed corticosteroid treatment independently, except according to an agreed clinical plan.

People with adrenal insufficiency should follow their personalised sick-day guidance and seek urgent medical help when symptoms suggest adrenal crisis.

Further information: NHS guidance on adrenal insufficiency and Addison's disease and NHS information about corticosteroids.

Why does brain fog fluctuate?

One of the most striking features of brain fog is that it can change considerably.

Someone may struggle to concentrate in the morning but feel clearer later in the day. Symptoms may worsen during infection, after poor sleep or during periods of increased physical activity.

Some people describe a marked improvement after treatment changes.

There are several possible explanations:

  • Inflammatory activity may fluctuate.
  • Sleep quality and fatigue vary from day to day.
  • Medication concentrations and effects change over time.
  • Cortisol availability and physiological requirements vary.
  • Pain, anxiety and physical exertion can affect concentration.
  • Blood oxygenation and ventilation may change during respiratory deterioration.

These factors can interact.

For example, an infection may increase inflammation, disrupt sleep, worsen fatigue and alter cortisol requirements simultaneously.

This makes it difficult to identify one cause simply by observing when brain fog appears.

Nevertheless, recognising patterns can be clinically useful.

What can patients do to help themselves?

There is currently no single established treatment for brain fog associated with aspergillosis.

However, that does not mean nothing can be done.

The most useful approach is often to look systematically for contributing factors that might be treatable.

1. Describe exactly what has changed

The phrase brain fog is useful, but clinicians may need more detail.

Try to describe specific difficulties:

  • Are you forgetting conversations?
  • Do you lose track of what people are saying?
  • Is reading or following instructions unusually difficult?
  • Do you struggle to find words?
  • Does thinking become harder as the day progresses?
  • Are you making mistakes in tasks you previously performed easily?

Explaining how symptoms affect daily functioning can be particularly powerful.

For example:

"I used to be able to follow complex conversations at work. Now I lose track halfway through and cannot always respond quickly enough."

This communicates much more than simply saying that concentration is poor.

2. Look for patterns

A short symptom diary may help identify changes associated with:

  • Respiratory exacerbations or infections.
  • Changes in corticosteroid dose or timing.
  • Antibiotic or antifungal treatment.
  • Poor sleep.
  • Increased physical or mental activity.
  • Episodes of breathlessness.
  • Changes in fatigue or general wellbeing.

A diary does not need to be complicated.

Recording symptom severity, medication changes and one or two relevant observations may be enough to reveal a useful pattern.

It can also provide a clearer picture for the clinical team than trying to remember several weeks of fluctuating symptoms during a short appointment.

3. Ask whether there are treatable medical contributors

Depending on the patient's history and symptoms, clinicians may consider:

  • Whether respiratory infection or inflammation is adequately controlled.
  • Whether oxygenation or ventilation needs assessment.
  • Whether medication adverse effects are contributing.
  • Whether corticosteroid treatment or adrenal function needs review.
  • Whether anaemia, thyroid dysfunction, vitamin deficiencies or metabolic disturbances might be involved.
  • Whether sleep disorders, pain, anxiety or depression are contributing.

Not every patient needs every investigation.

The aim is to avoid assuming that cognitive symptoms are simply an unavoidable part of chronic illness.

4. Manage mental energy

Even when the underlying cause cannot immediately be corrected, practical strategies may reduce the impact of brain fog.

These include:

  • Scheduling demanding tasks for times when concentration is usually better.
  • Breaking complex activities into shorter stages.
  • Taking regular breaks before mental exhaustion becomes overwhelming.
  • Using written reminders, calendars and checklists.
  • Reducing distractions when concentration is important.
  • Allowing extra time for decisions and unfamiliar tasks.
  • Avoiding unnecessary multitasking.

These approaches do not cure brain fog, but they may make everyday life more manageable.

Patients whose symptoms worsen substantially after exertion may need more individualised pacing advice rather than simply being encouraged to increase activity.

5. Consider support at work

For someone whose employment depends on concentration, memory or rapid decision-making, brain fog can be particularly distressing.

Occupational health services may help assess whether temporary or longer-term adjustments would be useful.

Depending on the role, adjustments might include additional breaks, altered working hours, reduced interruptions, written instructions or changes to particularly demanding duties.

In the UK, some people with long-term health conditions may be entitled to reasonable workplace adjustments under the Equality Act 2010.

Brain fog should not have to become severe enough to threaten someone's employment before its impact is taken seriously.

Further information: Acas guidance on reasonable adjustments at work.

When is brain fog something more urgent?

There is an important distinction between persistent cognitive difficulties and sudden confusion.

Brain fog often develops gradually or fluctuates over time.

Sudden confusion, disorientation, unusual drowsiness or a marked change in consciousness may indicate an acute medical problem.

Possible causes include severe infection, low oxygen levels, raised carbon dioxide, metabolic disturbances, medication effects or adrenal crisis.

New, sudden confusion requires urgent medical assessment. In the UK, call 999 if someone suddenly becomes confused, particularly if they are severely unwell.

New weakness affecting one side of the body, facial drooping or speech disturbance may indicate a stroke and also requires an immediate 999 call.

These symptoms should not be dismissed as ordinary brain fog.

Further information: NHS advice on sudden confusion and delirium.

What is research beginning to reveal?

Although brain fog remains poorly defined, scientific understanding is improving.

Researchers are increasingly recognising that cognitive symptoms occur across many different conditions, including chronic inflammatory illnesses, endocrine disorders and post-infectious syndromes.

Several areas of research are particularly promising.

How inflammation affects brain function

Scientists are investigating how immune signals influence the brain, including changes in neural communication, metabolism and the activity of immune cells within the nervous system.

This work may help explain why some people experience cognitive symptoms during or after illness.

However, findings from one condition cannot automatically be applied to aspergillosis.

The importance of cortisol rhythms

Cortisol normally follows a daily rhythm, with concentrations changing throughout the day and in response to physiological stress.

Conventional oral corticosteroid replacement does not always reproduce this pattern precisely.

Researchers are investigating whether more physiological replacement strategies can improve outcomes in people with adrenal insufficiency, including aspects of wellbeing and cognition.

This is relevant to patients who develop adrenal suppression after prolonged corticosteroid treatment.

Better ways to measure cognitive symptoms

Another important development is the increasing use of structured cognitive assessments and patient-reported outcome measures.

Instead of treating brain fog as a vague complaint, researchers are attempting to measure changes in attention, processing speed, memory and mental fatigue.

Better measurement may help identify different types of cognitive difficulty and determine whether treatments genuinely improve them.

Could treatments eventually become more targeted?

If researchers can distinguish brain fog caused predominantly by inflammation, hormonal disturbance, sleep disruption or other mechanisms, treatment may become more individualised.

A patient whose symptoms are driven by inadequate cortisol replacement would need a different approach from someone whose difficulties are associated with sleep disruption or persistent inflammatory disease.

This is a plausible direction for future research, rather than an established treatment strategy.

There is still considerable work to do, particularly in understanding cognitive symptoms associated specifically with CPA and ABPA.

Brain fog deserves to be taken seriously

For someone living with aspergillosis, brain fog can be among the most frustrating symptoms.

It affects abilities that are fundamental to everyday life: remembering, concentrating, communicating, working and making decisions.

Yet because it is invisible, its impact can easily be underestimated.

The woman who described struggling to continue her courtroom work illustrates this particularly clearly. Her difficulty was not simply feeling tired or occasionally forgetting something. It was the possibility that her illness or its treatment was interfering with the abilities her livelihood depended upon.

We should also remember that brain fog may have several causes operating together. The fact that a clinician cannot immediately identify one explanation does not mean the symptoms are imaginary.

There are reasons for cautious optimism.

Some contributing factors are already identifiable and treatable. Others are becoming better understood as researchers investigate the relationships between inflammation, hormones, sleep and brain function.

And the fact that brain fog can sometimes improve substantially, even after prolonged periods of difficulty, suggests that at least some of the underlying changes can be reversible.

For patients, the most important message is this:

Brain fog is real. It deserves proper attention. And although we do not yet have all the answers, there may be practical ways to reduce its impact today and better treatments in the future.

Further reading and useful resources

This article is intended for general information and does not replace individual medical advice. Patients should not alter prescribed corticosteroid doses without guidance from their clinical team or an established sick-day plan.